Cystic fibrosis clinical trials

Advanced Drug Delivery Reviews

Volumn 30, Issue 1-3, 1998, Pages 205-217

  Geddes, Duncan ^a   Alton, Eric ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cationic liposomes; CFTR; Cystic fibrosis; Gene therapy; Gene transfer

Indexed keywords

CELLS; DRUG PRODUCTS; GENES; GENETIC ENGINEERING; MEDICAL PROBLEMS; PROTEINS;

CATIONIC LIPOSOMES; CYSTIC FIBROSIS; GENE THERAPY;

DRUG THERAPY;

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COMPLEMENTARY DNA; GENZYME LIPID 67; LIPOSOME; SODIUM CHANNEL BLOCKING AGENT; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ETHICS; FOLLOW UP; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ION TRANSPORT; LUNG; NEBULIZATION; NONHUMAN; PATIENT INFORMATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

EID: 0032473554     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00117-8     Document Type: Review

References (69)

1. Welsh M.J. Abnormal regulation of ion channels in cystic fibrosis epithelia. FASEB J. 4:1990;2718-2725.
2. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O'Riordan C.R., Smith A.E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:1990;827-834.
3. Sheppard D.N., Rich D.P., Ostedgaard L.S., Gregory R.J., Smith A.E., Welsh M.J. Mutations in CFTR associated with mild-disease-form Cl-channels with altered pore properties. Nature. 362:1993;160-164.
4. Knowles M.R., Gatzy J.T., Boucher R.C. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. New Engl. J. Med. 305:1981;1489-1495.
5. Saiman L., Cacalano G., Gruenert D., Prince A. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect. Immun. 60:1992;2808-2814.
6. Pier G.B., Grout M., Zaidi T.S., Olsen J.C., Johnson L.G., Yankaskas J.R., Goldberg J.B. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 271(5245):1996;64-67.
7. Smith J.J., Travis S.M., Greenberg E.P., Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:1996;229-236.
8. App E.M., King M., Helfesreider R., Kohler D., Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. Am. Rev. Resp. Dis. 141:1990;605-612.
9. Knowles M.R., Church N.L., Waltner W.E., Yankaskas J.R., Gilligan P., King M., Edwards L.J., Helms R.W., Boucher R.C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. New Engl. J. Med. 322:1990;1189-1194.
10. Graham A., Hasani A., Alton E.W.F.W., Martin G.P., Marriott C., Hodson M.E., Clarke S.W., Geddes D.M. No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur. Respir. J. 6:1993;1243-1248.
11. Mason S.J., Paradiso A.M., Boucher R.C. Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human and normal cystic fibrosis airways. Br. J. Pharmacol. 103:1991;1649-1656.
12. Knowles M.R., Clarke L.L., Boucher R.C. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. New Engl. J. Med. 325:1991;533-538.
13. Engelhardt J.F., Yankaskas J.R., Ernst S.A., Yang Y., Marino C.R., Boucher R.C., Cohn J.A., Wilson J.M. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat. Genet. 2:1992;240-248.
14. Engelhardt J.F., Zepeda M., Cohn J.A., Yankaskas J.R., Wilson J.M. Expression of the cystic fibrosis gene in adult human lung. J. Clin. Invest. 93:1994;737-749.
15. Crawford I., Maloney P.C., Zeitlin P.L., Guggino W.B., Hyde S.C., Turley H., Gatter K.C., Harris A., Higgins C.F. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc. Natl. Acad. Sci. 88:1991;9262-9266.
16. Dorin J.R., Stevenson B.J., Fleming S., Alton E.W., Dickinson P., Porteous D.J. Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mammalian Genome. 5(8):1994;465-472.
17. Johnson L.G., Olsen J.C., Sarkadi B., Moore K.L., Swanstrom R., Boucher R.C. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2:1992;21-25.
18. Dorin J.R., Farley R., Webb S., Smith S.N., Farini E., Delaney S.J., Wainwright B.J., Alton E.W.F.W., Porteous D.J. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 3(9):1996;797-801.
19. Wert S.E., Glasser S.W., Korfhagan T.R., Whitsett J.A. Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice. Develop. Biol. 156:1993;426-443.
20. Alton E.W.F.W., Middleton P.G., Caplen N.J., Smith S.N., Steel D.M., Munkonge F.M., Jeffery P.K., Geddes D.M., Hart S.L., Williamson R., Fasold K.I., Miller A.D., Dickinson P., Stevenson B.J., McLachlan G., Dorin J.R., Porteous D.J. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5:1993;135-142.
21. Coutelle C., Caplen N., Hart S., Huxley C., Williamson R. Gene therapy for cystic fibrosis. Arch. Dis. Child. 68:1993;437-443.
22. Wilson J. Vehicles for gene therapy. Nature. 365:1993;691-692.
23. Rosenfeld M.A., Chu C.-S., Seth P., Danel C., Banks T., Yoneyama K., Yoshimura K., Crystal R.G. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5:1994;331-342.
24. Zabner J., Petersen D.M., Puga A.P., Graham S.M., Couture L.A., Keyes L.D., Lukason M.J., St. George J.A., Gregory R.J., Smith A.E., Welsh M.J. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6:1994;75-83.
25. Trapnell B. Adenoviral vectors for gene transfer. Adv. Drug Deliv. Rev. 12:1993;185-199.
26. Simon R.H., Engelhardt J.F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4:1993;771-780.
27. Rosenfeld M.A., Yoshimura K., Trapnell B.C., Yoneyama K., Rosenthal E.R., Dalemans W., Fukayama M., Bargon J., Stier L.E., Stratford-Perricaudet L., Perricaudet M., Guggino W.B., Pavirani A., Lecocq J.-P., Crystal R.G. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68:1992;143-155.
28. Yang Y., Nunes F.A., Berencsi K., Gönczöl E., Engelhardt J.F., Wilson J.M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:1994;362-369.
29. Yei S., Mittereder N., Tang K., O'Sullivan C., Trapnell B. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:1994;192-200.
30. Cotten M., Wagner E., Zatloukal K., Phillips S., Curiel D.T., Birnstiel M.L. High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. 89:1992;6094-6098.
31. Kaneda Y., Iwai K., Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science. 243:1989;375-378.
32. Zhu N., Liggit D., Lui Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
33. Alton E.W., Currie D., Logan-Sinclair R., Warner J.O., Hodson M.E., Geddes D.M. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur. Resp. J. 3:1990;922-926.
34. Knowles M., Gatzy J., Boucher R. Relative ion permeabilities of normal and cystic fibrosis nasal epithelium. J. Clin. Invest. 71:1983;1410-1417.
35. Middleton P.G., Caplen N.J., Gao X., Huang L., Gaya H., Geddes D.M., Alton E.W.F.W. Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. Eur. Resp. J. 7:1994;442-445.
36. Tsang V.T., Alton E.W.F.W., Hodson M.E., Yacoub M. In vitro bioelectric properties of bronchial epithelium from transplanted lungs in recipients with cystic fibrosis. Thorax. 48:1993;1006-1011.
37. Grygorczyk R., Bridges M.A. Whole-cell chloride conductances in cultured brushed human nasal epithelial cells. Can. J. Physiol. Pharmacol. 70:1992;1134-1141.
38. Stern M., Munkonge R.M., Caplen N.J., Sorgi F., Huang L., Geddes D.M., Alton E.W.F.W. Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects. Gene Ther. 2:1995;766-774.
39. Verkman A. Development and biological applications of chloride-sensitive fluorescent indicators. Am. J. Physiol. 259:1990;C375-C388.
40. Barasch J., Kiss B., Prince A., Saiman L., Gruenert D., Al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature. 352:1991;70-73.
41. Bradbury N.A., Jilling T., Berta G., Sorscher E.J., Bridges R.J., Kirk K.L. Regulation of plasma membrane recycling by CFTR. Science. 256:1992;530-532.
42. Saiman L., Prince A. Pseudomonas aeruginosa pili bind asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92:1993;1875-1890.
43. Schwab U.E., Wold A.E., Carson J.L., Leigh M.W., Cheng P.-W., Gilligan P.H., Boat T.F. Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am. Rev. Respir. Dis. 148:1993;365-369.
44. Plotkowski M.C., Chevillard M., Pierrot D., Altemayer D., Puchelle E. Epithelial respiratory cells from cystic fibrosis patients do not possess specific Pseudomonas aeruginosa-adhesive properties. J. Med. Microbiol. 36:1992;104-111.
45. Drumm M.L., Pope H.A., Cliff W.H., Rommens J.M., Marvin S.A., Tsui L.-C., Collins F.S., Frizzell R.A., Wilson J.M. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell. 62:1990;1227-1233.
46. Rich D.P., Anderson M.P., Gregory R.J. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride regulation in cystic fibrosis airway epithelial cells. Nature. 347:1990;358-363.
47. - channels by protein kinase A corrected by insertion of CFTR. Nature. 358:1992;581-584.
48. Rosenfeld M.A., Yoshimura K., Trapnell B.C., Yoneyama K., Rosenthal E.R., Dalemans W., Fukayama M., Bargon J., Stier L.E., Stratford-Perricaudet L., Perricaudet M., Guggino W.B., Pavirani A., Lecocq J.-P., Crystal R.G. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68:1992;143-155.
49. Yoshimura K., Rosenfeld M.A., Nakamura H., Scherer E.M., Pavirani A., Lecocq J.-P., Crystal R.G. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucl. Acids Res. 20:1992;3233-3240.
50. Engelhardt J.F., Yang Y., Stratford-Perricaudet L.D., Allen E.D., Kozarsky K., Perricaudet M., Yankaskas J.R., Wilson J.M. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat. Genet. 4:1993;27-34.
51. Whitsett J.A., Dey C.R., Stripp B.R., Wikenheiser K.A., Clark J.C., Wert S.E., Gregory R.J., Smith A.E., Cohn J.A., Wilson J.M., Engelhardt J. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice. Nat. Genet. 2:1992;13-20.
52. S.H. Schiavi et al. (1993) Evidence for toxic effects of overexpression of CFTR in vitro and in vivo. 7th North American CF Conference "late breaking science".
53. Hyde S.C., Gill D.R., Higgins C.F., Treziser A.E., MacVinish C.J., Cuthbert A.W., Ratcliff R., Evans M.J., Colledge W.H. Correction of ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature. 362:1993;250-255.
54. Engelhardt J.F., Simon R.H., Yang Y., Zepeda M., Weber-Pendleton S., Doranz B., Grossman M., Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:1993;759-769.
55. Bout A., Perricaudet M., Baskin G., Imler J.-L., Scholte B.J., Pavirani A., Valerio D. Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum. Gene Ther. 5:1994;3-10.
56. Flotte T.R., Afione S.A., Solow R., Drumm M.L., Markakis D., Guggino W.B., Zeitlin R.L., Carter B.J. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268:1993;378-390.
57. Gao X.A., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:1991;280-285.
58. Nabel G.J., Nabel E.G., Yang Z.-Y., Fox B.A., Plautz G.E., Gao X., Huang L., Shu S., Gordon D., Chang A.E. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. 90:1993;11307-11311.
59. Tizzano E.F., Chitayat D., Buchwald M. Cell-specific localisation of CFTR mRNA shows developmentally regulated expression inhuman fetal tissues. Hum. Mol. Genet. 2:1993;219-224.
60. Tresize A.E.O., Chambers J.A., Wardle C.J., Gould S., Harris A. Expression of the cystic fibrosis gene in human foetal tissues. Hum. Mol. Genet. 2:1993;213-218.
61. Caplen N.J., Gao X., Hayes P., Elaswarapu R., Fisher G., Kinrade E., Chakera A., Schorr J., Hughes B., Dorin J.R., Porteous D.J., Alton E.W.F.W., Geddes D.M., Coutelle C., Williamson R., Huang L., Gilchrist C. Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process. Gene Ther. 1:1994;139-147.
62. X. Clothier, Report of the Committee considering the Ethics of Human Gene Therapy (1992).
63. Zabner J., Couture L.A., Gregory R.J., Graham S.M., Smith A.E., Welsh M.J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with CF. Cell. 75:1993;207-216.
64. Crystal R.G., McElvaney N.G., Rosenfeld M.A., Chu C.-S., Mastrangeli A., Hay J.G., Broday S.L., Jaffe H.A., Eissa N.T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:1994;42-51.
65. Knowles M.R., Hohneker K.W., Zhou Z., Olsen J.C., Noah T.L., Hu P., Leigh M.W., Gngelhardt J.R., Edwards L.J., Jones K.R., Grossman M., Wilson M.J., Johnson L.G., Boucher R.C. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl. J. Med. 333:1995;823-831.
66. Caplen N.J., Alton E.W.F.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., Coutelle C., Huang L., Porteous D.J., Williamson R., Geddes D.M. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1:1995;39-46.
67. Porteous D.S., Dorin J.R., McLachlan G., Davidson-Smith H., Davidson H., Stevenson B.J., Carothers A.D., Wallace A.J., Moralle S., Hoenes C., Kallmeyer G., Michaelis U., Naujoks K., Ho L.-P., Samways J.M., Imrie M., Greening A.P., Innes J.A. Evidence for safety and efficency of DOTAP cationic liposome mediated CFTR gene transfer to nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:1997;210-218.
68. Gill D.R., Southern K.W., Mofford K.A., Seddon T., Huang L., Sorgi F., Thomson A., MacVinish L.J., Ratcliff R., Bilton D., Lane D.J., Littlewood J.M., Webb A.K., Middleton P.G., Colledge W.H., Cuthbert A.W., Evans M.J., Higgins C.S., Hyde S.C. A placebo controlled study of liposome mediated gene transfer to nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:1997;199-209.
69. Geddes D. Designing clinical trials for gene therapy. J. Inher. Metab. Dis. 18:1995;517-524.